Literature DB >> 19102039

Clinical spectrum of patients with a Brugada ECG.

Steven J Fowler1, Silvia G Priori.   

Abstract

PURPOSE OF REVIEW: The Brugada syndrome continues to spark intensive investigation since its earliest description. New insight has been gained regarding the genetic, histopathologic, and metabolic mechanisms of this heritable channelopathy - a heterogeneity that is reflected in the diverse clinical presentation. In this review, we will focus on clinical spectrum of patients with a Brugada ECG pattern with a special focus on diagnosis and risk stratification. RECENT
FINDINGS: In the past year, multiple case reports have demonstrated that the Brugada ECG pattern is not limited to those with the diagnosed syndrome, with increasing evidence that an 'overlap' exists among inherited channelopathies, especially those involving the sodium and calcium channels.
SUMMARY: The clinical spectrum of patients with a Brugada ECG remains broad, reflecting the heterogeneity of the underlying pathophysiology. As the true prevalence of the disease unfolds, knowledge regarding the clinical spectrum of patients with a Brugada ECG is important to implement effective risk stratification and management. It may be proposed that the ECG pattern of ST-segment elevation in the right precordial leads should not be seen as a marker of a specific syndrome, but rather as a common electrical expression of structural abnormalities in the right ventricle that may have genetic, infective, or inflammatory origins.

Entities:  

Mesh:

Year:  2009        PMID: 19102039     DOI: 10.1097/hco.0b013e32831cb920

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  8 in total

Review 1.  Phenotypical manifestations of mutations in the genes encoding subunits of the cardiac voltage-dependent L-type calcium channel.

Authors:  Carlo Napolitano; Charles Antzelevitch
Journal:  Circ Res       Date:  2011-03-04       Impact factor: 17.367

2.  Unique sleep disorders profile of a population-based sample of 747 Hmong immigrants in Wisconsin.

Authors:  Eric Young; Se Xiong; Laurel Finn; Terry Young
Journal:  Soc Sci Med       Date:  2012-07-02       Impact factor: 4.634

Review 3.  Practical Aspects in Genetic Testing for Cardiomyopathies and Channelopathies.

Authors:  Han-Chih Hencher Lee; Chor-Kwan Ching
Journal:  Clin Biochem Rev       Date:  2019-11

4.  Sleep-disordered breathing in patients with the Brugada syndrome.

Authors:  Paula G Macedo; Josep Brugada; Pavel Leinveber; Begoña Benito; Irma Molina; Fatima Sert-Kuniyoshi; Taro Adachi; Jan Bukartyk; Christelle van der Walt; Tomas Konecny; Shantal Maharaj; Tomas Kara; Josep Montserrat; Virend Somers
Journal:  Am J Cardiol       Date:  2011-01-19       Impact factor: 2.778

5.  A Rare yet Morbid Complication of Cocaine Use: Brugada Type 1 on Electrocardiogram.

Authors:  Muhammad Atif Masood Noori; Hardik Fichadiya; Shruti Jesani; Fareeha Abid; Nikhita Sachdeva; Hasham Saeed; Qirat Jawed; Sherif Elkattawy; Meherwan Joshi
Journal:  Cureus       Date:  2022-04-20

6.  Risk stratification in individuals with the Brugada type 1 ECG pattern without previous cardiac arrest: usefulness of a combined clinical and electrophysiologic approach.

Authors:  Pietro Delise; Giuseppe Allocca; Elena Marras; Carla Giustetto; Fiorenzo Gaita; Luigi Sciarra; Leonardo Calo; Alessandro Proclemer; Marta Marziali; Luca Rebellato; Giuseppe Berton; Leonardo Coro; Nadir Sitta
Journal:  Eur Heart J       Date:  2010-10-26       Impact factor: 29.983

7.  Strategies for the prevention and treatment of sudden cardiac death.

Authors:  Emad F Aziz; Fahad Javed; Balaji Pratap; Eyal Herzog
Journal:  Open Access Emerg Med       Date:  2010-12

8.  C-reactive protein levels in the brugada syndrome.

Authors:  Aimé Bonny; Joelci Tonet; Manlio F Márquez; Antonio De Sisti; Abdou Temfemo; Caroline Himbert; Fatima Gueffaf; Fabrice Larrazet; Ivo Ditah; Robert Frank; Françoise Hidden-Lucet; Guy Fontaine
Journal:  Cardiol Res Pract       Date:  2011-11-29       Impact factor: 1.866

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.